They've been gaining traction in the last few quarters and telehealth use (I can't see how doctor can do respiratory consultation remotely without using ResAppDx) will drive clinic and then eventually ED use (this will take the longest) which will then cover all environment for all age demographic.
RAP Price at posting:
11.5¢ Sentiment: Buy Disclosure: Held